Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,513.67
(
0.93%
)
US TECH 100
28,866.72
(
0.97%
)
Dow Jones
50,104.74
(
0.83%
)
Brent Oil
102.59
(
-1.06%
)
Bitcoin
81,508.36
(
2.80%
)
News Focus
News Focus
Post# of 257560
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: investorgold2002 post# 118757

Sunday, 04/24/2011 12:57:14 AM

Sunday, April 24, 2011 12:57:14 AM

Post# of 257560
A direct comparison of BG-12 and Copaxone is being done in the phase-3 ‘CONFIRM’ study, which is scheduled to report data in Sep 2011:

http://clinicaltrials.gov/ct2/show/NCT00451451

There are no prior studies with a head-to-head comparison of these two drugs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today